Serenex Announces Participation at the 2007 Biotechnology Industry Organization (BIO) Business Forum

DURHAM, NC -- (MARKET WIRE) -- May 03, 2007 -- Serenex, Inc., an integrated oncology-focused drug discovery and development company, announced today that Dr. Richard Kent, chief executive officer, is scheduled to present at the BIO Business Forum taking place at the 2007 BIO International Convention at the Boston Convention & Exhibition Center.
MORE ON THIS TOPIC